CompanyGraph
At a glance
- Depends onDownstream position: depends on 12 industries, supplies 7
- ScaleMarket cap is $2.63B, above the global median of $1.15B
- PositionDebt-to-equity is 3.81×, higher than 95% of its Medical Care Facilities peers (median 0.38×)
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.25BEUR2.63B · vs all stocks (USD)
Revenue (TTM)
6.00BEUR7.01B · vs all stocks (USD)
Profit Margin
-3.36%vs Medical Care Facilities peers
Beta
0.6330xvs all stocks
52-Week Change
-6.61%vs all stocks
Market Capitalization
2.25BEUR2.63B · vs all stocks (USD)
Enterprise Value
10.44BEUR12.20B · vs all stocks (USD)
Forward P/E
70.85xvs Medical Care Facilities peers
Price to Sales (TTM)
0.3806xvs Medical Care Facilities peers
Price to Book (MRQ)
1.68xvs Medical Care Facilities peers
Enterprise to Revenue
1.74xvs Medical Care Facilities peers
Enterprise to EBITDA
18.31xvs Medical Care Facilities peers
Profit Margin
-3.36%vs Medical Care Facilities peers
Operating Margin
6.21%vs Medical Care Facilities peers
Return on Assets (TTM)
1.22%vs Medical Care Facilities peers
Return on Equity (TTM)
-10.64%vs Medical Care Facilities peers
Revenue (TTM)
6.00BEUR7.01B · vs all stocks (USD)
Revenue per Share (TTM)
37.33EURUpdated Aug 21, 2026Quarterly Revenue Growth
3.50%vs Medical Care Facilities peers
Gross Profit (TTM)
875.20MEUR1.02B · vs all stocks (USD)
EBITDA (TTM)
830.91MEUR970.72M · vs all stocks (USD)
Net Income (TTM)
-196.04MEUR-229.02M · vs all stocks (USD)
Operating Cash Flow (TTM)
600.55MEUR701.60M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
640.83MEUR748.66M · vs all stocks (USD)
5-Year Average Dividend Yield
1.06%vs all stocks
Payout Ratio
0.00%vs Medical Care Facilities peers
Minority Interest (Equity)
822.00KEURFY2025 · Dec 31, 2025Revenue
5.90BEURFY2025 · Dec 31, 2025Cost of Goods Sold
1.13BEURFY2025 · Dec 31, 2025Gross Profit
4.76BEURFY2025 · Dec 31, 2025Operating Income
173.25MEUR202.40M · vs all stocks (USD)
Pre-tax Income
-263.88MEURFY2025 · Dec 31, 2025Income Tax Expense
34.50MEURFY2025 · Dec 31, 2025Net Income
-298.90MEURFY2025 · Dec 31, 2025EBIT
80.14MEURFY2025 · Dec 31, 2025EBITDA (Income Statement)
830.91MEURFY2025 · Dec 31, 2025Other Operating Expenses
48.82MEURFY2025 · Dec 31, 2025Non-operating Interest Income
5.50MEURFY2025 · Dec 31, 2025Non-operating Interest Expense
344.02MEURFY2025 · Dec 31, 2025Net Income from Continuing Operations
-298.90MEURFY2025 · Dec 31, 2025Minority Interests (P&L)
500.00KEURFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00EURFY2025 · Dec 31, 2025Operating Cash Flow
167.50MEURFY2025 · Dec 31, 2025Free Cash Flow
1.59MEURFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
337.09MEURFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-298.90MEURFY2025 · Dec 31, 2025Other Non-cash Items
658.86MEURFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-140.27MEURFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-52.20MEURFY2025 · Dec 31, 2025Capital Expenditures
-165.91MEURFY2025 · Dec 31, 2025Net Acquisitions
-25.36MEURFY2025 · Dec 31, 2025Net Investing Cash Flow
-191.27MEURFY2025 · Dec 31, 2025Long-term Debt Issuance
3.50BEURFY2025 · Dec 31, 2025Long-term Debt Payments
-3.81BEURFY2025 · Dec 31, 2025Other Financing Charges
-1.00KEURFY2025 · Dec 31, 2025Net Financing Cash Flow
-310.29MEURFY2025 · Dec 31, 2025Shares Outstanding
160.26MSharesUpdated Aug 21, 2026Float Shares
124.07MSharesUpdated Aug 21, 2026% Held by Insiders
0.00%vs all stocks
% Held by Institutions
59.82%vs all stocks
Total Cash (MRQ)
590.89MEUR690.31M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.69EURUpdated Aug 21, 2026Total Debt (MRQ)
8.02BEUR9.37B · vs all stocks (USD)
Total Debt to Equity (MRQ)
3.81xvs Medical Care Facilities peers
Current Ratio (MRQ)
0.8250xvs Medical Care Facilities peers
Book Value per Share (MRQ)
8.42EURUpdated Aug 21, 2026Total Assets
12.65BEUR14.78B · vs all stocks (USD)
Total Current Assets
1.74BEURFY2025 · Dec 31, 2025Total Liabilities
11.25BEURFY2025 · Dec 31, 2025Total Non-current Assets
10.92BEURFY2025 · Dec 31, 2025Total Non-current Liabilities
8.51BEURFY2025 · Dec 31, 2025Total Current Liabilities
2.73BEURFY2025 · Dec 31, 2025Cash & Cash Equivalents
337.09MEURFY2025 · Dec 31, 2025Accounts Receivable
665.52MEURFY2025 · Dec 31, 2025Inventory
14.66MEURFY2025 · Dec 31, 2025Accounts Payable
554.66MEURFY2025 · Dec 31, 2025Short-term Debt
769.60MEURFY2025 · Dec 31, 2025Other Current Liabilities
380.44MEURFY2025 · Dec 31, 2025Long-term Debt
7.84BEURFY2025 · Dec 31, 2025Other Non-current Liabilities
-179.06MEURFY2025 · Dec 31, 2025Common Stock (Book)
1.61MEURFY2025 · Dec 31, 2025Retained Earnings
-298.40MEURFY2025 · Dec 31, 2025Total Shareholders' Equity
1.41BEUR1.65B · vs all stocks (USD)
52-Week Low
10.72EURUpdated Aug 21, 202652-Week High
16.19EURUpdated Aug 21, 202652-Week Change
-6.61%vs all stocks
Beta
0.6330xvs all stocks
50-Day MA
14.12EURUpdated Aug 21, 2026200-Day MA
14.05EURUpdated Aug 21, 2026Avg 10-Day Volume
152.37KSharesUpdated Aug 21, 2026Avg 30-Day Volume
179.99KSharesUpdated Aug 21, 2026Diluted EPS (TTM)
-1.22EURUpdated Aug 21, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Within or Near the Altman Distress Zone
Debt is a large share of its assets, and large against its cash flow.
Reads
Elevated Leverage on Three Denominators
Debt sits high against its equity, its assets, and its cash flow.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Debt-to-equity is 3.81×, higher than 95% of its Medical Care Facilities peers (median 0.38×)Significant
Debt-to-equity: 3.81Industry median: 0.38Industry P95: 2.24Peers compared: 70.00
Financial Health
Altman Z-Score 0.48: distress zoneCritical
Altman Z-Score: 0.48
Supply Chain
Downstream position: depends on 12 industries, supplies 7Notable
Outgoing: 7.00Incoming: 12.00
High connectivity hub: 19 industry connectionsNotable
Total Connections: 19.00
Scale
Market cap is $2.63B, above the global median of $1.15BNotable
Market cap (USD): 2,631,064,352.636Global Median: 1,146,734,693.424
Revenue is $7.01B, above the global median of $520.53MNotable
Revenue (USD): 7,007,805,030.482Global Median: 520,528,949.311
Levered free cash flow is $748.66M, above the global median of $16.24MNotable
Levered free cash flow (USD): 748,659,289.544Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Orpea
Tier 1RuleThroughput-Bound ConversionProductionFlow
Chorus Limited
Tier 1RuleThroughput-Bound ConversionFlowProduction
P3 Health Partners Inc.
Tier 1RuleThroughput-Bound ConversionRiskFlow
Pediatrix Medical Group, Inc.
Tier 1RuleThroughput-Bound ConversionProductionFlow
Realord Group Holdings Ltd.
Tier 1RuleThroughput-Bound ConversionFlowInterface
Addus HomeCare Corporation
Tier 1RuleThroughput-Bound ConversionProductionFlow
Kyivstar Group Ltd.
Tier 1RuleThroughput-Bound ConversionFlowProduction
Select Medical Holdings Corp.
Tier 1RuleThroughput-Bound ConversionProductionRisk
Brookdale Senior Living Inc.
Tier 1RuleThroughput-Bound ConversionFlowProduction
Holding Company ADMIE IPTO S.A.
Tier 1RuleThroughput-Bound ConversionFlowProduction
Companies that share active interpretations — structural patterns currently present in both stocks.
Shandong Longda Meishi Co., Ltd.
2 interpretationsWithin or Near the Altman Distress ZoneElevated Leverage on Three Denominators
China High-Speed Railway Co., Ltd.
2 interpretationsWithin or Near the Altman Distress ZoneElevated Leverage on Three Denominators
Yorhe Fluid Intelligent Control Co., Ltd.
2 interpretationsWithin or Near the Altman Distress ZoneElevated Leverage on Three Denominators